Skip to content
AiSeekAiSeek
Sign in
Lupin Receives FDA Approval for Phytonadione Injectable EmulsionAI illustration
NewHealthReported 2026-10-09 03:16

Lupin Receives FDA Approval for Phytonadione Injectable Emulsion

Lupin Limited has received FDA approval for its ANDA for Phytonadione Injectable Emulsion, indicating bioequivalence to the reference drug and approval for treating hypoprothrombinemia and vitamin K-deficiency.

In depthRead the in-depth story

Why it matters. Lupin's approval for Phytonadione Injectable Emulsion expands its product portfolio and strengthens its position in the U.S. pharmaceutical market.

01

Who it touches

  1. 1Lupin Limited
  2. located in →Fact
    2MumbaiGeography
02

Evidence

  • PPR Newswire news releasesCompany2026-10-09 03:16
    The U.S. FDA has approved Lupin's Phytonadione Injectable Emulsion USP, 1 mg/0.5 mL Single-dose Prefilled Syringe
    View source
  • PPR Newswire news releasesCompany2026-10-09 03:16
    Phytonadione Injectable Emulsion had estimated annual sales of USD 52.3 million in the U.S. (IQVIA MAT Aug 2026).
    View source
  • GGDELT Global Knowledge GraphMedia2026-10-09 03:45
    View source
  • GGDELT Global Knowledge GraphMedia2026-10-09 04:15
    View source
  • GGDELT Global Knowledge GraphMedia2026-10-09 04:15
    View source
  • GGDELT Global Knowledge GraphMedia2026-10-09 04:15
    View source
  • GGDELT Global Knowledge GraphMedia2026-10-09 03:45
    View source
  • GGDELT Global Knowledge GraphMedia2026-10-09 04:15
    View source
  • GGDELT Global Knowledge GraphMedia2026-10-09 04:15
    View source
  • GGDELT Global Knowledge GraphMedia2026-10-09 04:15
    View source
  • GGDELT Global Knowledge GraphMedia2026-10-09 04:15
    View source
  • GGDELT Global Knowledge GraphMedia2026-10-09 03:45
    View source